Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use

Clinical trial NCT01223456 · TERMINATED

Trial details

NCT number: NCT01223456
Sponsor: AstraZeneca
Status: TERMINATED
Study type: OBSERVATIONAL

Type 2 Diabetes Mellitus

Start date: 2010-10-01
Primary completion: 2012-12-01
Enrollment: 542

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.